ERASCA INC.
ERASCA INC. logo
ERAS

ERASCA INC. (ERAS)

$7.342.78%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$6.95
Day's Range
$7.515
$4.51
52-Week Range
$16.01
1 month return0.14%
3 month return16.97%
1 year return51.65%
5 year return57.89%

Company Information

At Erasca, its name is its mission: To erase cancer. Erasca is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. Erasca has assembled what the company believes to be the deepest RAS/MAPK pathway-focused pipeline in the industry. Erasca believes its team’s capabilities and experience, further guided by its scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position the company to achieve its bold mission of erasing cancer.
OrganizationERASCA INC.
Employees123
CEODr. Jonathan E. Lim M.D.
IndustryServices

Analyst Recommendation

based on 5 analysts ratings

Buy
80%
Buy
20%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for ERASCA INC.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 177.93%

Current

$7.34

Target

$20.4

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
4
9
9
Hold
1
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
923.8M
Book Value
$2.99
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.56
Wall Street Target Price
20.4

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.38
Enterprise Value
567.3M
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-4.16

Technicals

50 Day MA
7.56
200 Day MA
7.97

Institutional Holdings

FMR Inc

15.1%

ARCH VENTURE CORP

9.13%

Cormorant Asset Management, LLC

8.68%

Partner Fund Management LP

4.86%

Vanguard Group Inc

4.63%

AllianceBernstein L.P.

3.36%

Discover more

Frequently Asked Questions

What is ERASCA INC. share price today?

Can Indians buy ERASCA INC. shares?

How can I buy ERASCA INC. shares from India?

Can Fractional shares of ERASCA INC. be purchased?

What are the documents required to start investing in ERASCA INC. stocks?

What are today’s High and Low prices of ERASCA INC.?

What are today’s traded volumes of ERASCA INC.?

What is today’s market capitalisation of ERASCA INC.?

What is the 52 Week High and Low Range of ERASCA INC.?

How much percentage ERASCA INC. is down from its 52 Week High?

How much percentage ERASCA INC. is up from its 52 Week low?

What are the historical returns of ERASCA INC.?

Who is the Chief Executive Officer (CEO) of ERASCA INC.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*